Image Image Image Image Image Image Image Image Image Image Image Image

| December 12, 2018

Scroll to top

Top

No Comments

Why Merck Is Betting Big on One Cancer Drug -

Merck is making one of the biggest bets on a single drug in the pharmaceutical industry, a move that is risky but that could, if successful, pay off for the company and cancer patients.
WSJ.com: US Business

Submit a Comment